CEP8983, with the CAS number 374071-46-2, is a small molecule that functions primarily as a selective inhibitor of the protein kinase activity of the Janus kinase (JAK) family. This compound has garnered attention in the field of medicinal chemistry and pharmacology due to its potential therapeutic applications, particularly in the treatment of various autoimmune diseases and certain types of cancers. CEP8983 exhibits a specific binding affinity for JAKs, which play a crucial role in the signaling pathways of several cytokines and growth factors. The inhibition of these kinases can modulate immune responses and cellular proliferation. In terms of its chemical structure, CEP8983 features a unique arrangement of functional groups that contribute to its biological activity and selectivity. Additionally, its pharmacokinetic properties, such as solubility and metabolic stability, are essential for its efficacy and safety profile in clinical settings. Ongoing research continues to explore its full potential and mechanisms of action in various disease models.

CEP8983

374071-46-2: CEP8983, with the CAS number 374071-46-2, is a small molecule that functions primarily as a selective inhibitor of the protein kinase activity of the Janus kinase (JAK) family. This compound has garnered attention in the field of medicinal chemistry and pharmacology due to its potential therapeutic applications, particularly in the treatment of various autoimmune diseases and certain types of cancers. CEP8983 exhibits a specific binding affinity for JAKs, which play a crucial role in the signaling pathways of several cytokines and growth factors. The inhibition of these kinases can modulate immune responses and cellular proliferation. In terms of its chemical structure, CEP8983 features a unique arrangement of functional groups that contribute to its biological activity and selectivity. Additionally, its pharmacokinetic properties, such as solubility and metabolic stability, are essential for its efficacy and safety profile in clinical settings. Ongoing research continues to explore its full potential and mechanisms of action in various disease models.

<p>CEP-8983 is a PARP inhibitor potentially for the treatment of solid tumours.</p>

CAS 374071-46-2

CEP8983

CEP-8983

Ref: TM-T26979